FDA 483 data is just the tip of the iceberg
AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs
inspectorprofile icon

Sean Creighton InspectorProfile

$1,493 - Available for instant download

This FDA InspectorProfile is a report of relevant audit-related information on Sean Creighton, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Medical Devices & Rad Health.

Product Description

This InspectorProfile report is updated through and lists Sean Creighton's inspections in 33 countries: United States, India, Taiwan, Israel, Ireland, Germany, China, United Kingdom, Hungary, Costa Rica, Japan, Malaysia, Denmark, Switzerland, Austria, Poland, Romania, Serbia, Dominican Republic (the), Sweden, Singapore, South Africa, Korea (the Republic of), Belgium, Taiwan (Province of China), Netherlands, Czech Republic, Estonia, France, Finland, Hong Kong SAR, Canada, and Argentina.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Sean Creighton's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Sean Creighton.

FDA InspectorProfile Overview Example
FDA InspectorProfile Metrics Example
FDA InspectorProfile Citations Example
FDA InspectorProfile Inspections List

Product details

  • Sean Creighton's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Sean Creighton has conducted including:

Note: The EIR and 483 documents are sold separately.